Dealing with Pharmaceutical Supply-Chain Complexities

The new building will create 150 new jobs and expands total production area to nearly 12,000 square meters.

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.

The agreement, which covers a period of five years, has been designed to offer a turnkey service to companies seeking faster time to market for ADCs and bioconjugates.